Literature DB >> 2019834

Mortality rates from multiple sclerosis: geographical and temporal variations revisited.

E S Williams1, D R Jones, R O McKeran.   

Abstract

A review of the United Kingdom (UK) multiple sclerosis (MS) literature suggests that over the last three decades prevalence and estimated incidence rates have increased, while mortality rates have been declining. UK mortality data over a 30 year period have been studied to examine temporal and geographical variations, to estimate changes in survival, and to examine the relationship between mortality and morbidity trends. The study has shown an overall decline in mortality throughout the UK of approximately 25% over the 30 year period ending in 1983, and a reduction in the mortality differential between Scotland, and England and Wales, but no positive correlation has been found between mortality and morbidity. The overall decline in death rate in females was 23% and in males 30% over the 30 years of the survey. The total number of deaths declined by 39% between the five year periods 1954-58 and 1979-83 in Scotland compared with a 10% decline for England and Wales. Estimated median age of death increased from 52 to 59 years and the improvement in survival over the period of study was similar for both countries and is unlikely to have contributed to the reduction in mortality differential. Within England and Wales regional mortality rates did not show a clear north-south gradient. The decline in the mortality differential between Scotland and England (if not artefactual) may provide an important aetiological clue in the search for the cause of multiple sclerosis, and the rate of decline suggests an environmental rather than a genetic aetiology.

Entities:  

Mesh:

Year:  1991        PMID: 2019834      PMCID: PMC1014342          DOI: 10.1136/jnnp.54.2.104

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Epidemiological studies in Cornwall.

Authors:  E R HARGREAVES
Journal:  Proc R Soc Med       Date:  1961-03

2.  Observations on the prevalence of multiple sclerosis in Northern Scotland.

Authors:  J M SUTHERLAND
Journal:  Brain       Date:  1956-12       Impact factor: 13.501

3.  Prevalence of multiple sclerosis in a south London borough.

Authors:  E S Williams; R O McKeran
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

4.  The distribution of multiple sclerosis in the United Kingdom.

Authors:  R J Swingler; D Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

5.  A further prevalence study of multiple sclerosis in north-east Scotland.

Authors:  D I Shepherd; A W Downie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

6.  Statistical age-period-cohort analysis: a review and critique.

Authors:  L L Kupper; J M Janis; A Karmous; B G Greenberg
Journal:  J Chronic Dis       Date:  1985

7.  Prevalence of multiple sclerosis in north-east Scotland.

Authors:  D I Shepherd; A W Downie
Journal:  Br Med J       Date:  1978-07-29

8.  Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.

Authors:  D C Poskanzer; L B Prenney; J L Sheridan; J Y Kondy
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

9.  The analysis of mortality by the subject-years method.

Authors:  G Berry
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

10.  Prevalence of disseminated sclerosis in Northern Ireland.

Authors:  R S ALLISON; J H MILLAR
Journal:  Ulster Med J       Date:  1954-03
View more
  8 in total

1.  Multiple sclerosis in the north Cambridgeshire districts of East Anglia.

Authors:  M Rice-Oxley; E S Williams; R O McKeran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

2.  The prevalence of multiple sclerosis in the Leeds Health Authority.

Authors:  H L Ford; E Gerry; C M Airey; A Vail; M H Johnson; D R Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  Prevalence of multiple sclerosis in Rochdale.

Authors:  D I Shepherd; A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

4.  Surveying multiple sclerosis in the United Kingdom.

Authors:  N Robertson; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

5.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

6.  Multiple sclerosis in the Cambridge health district of east Anglia.

Authors:  C J Mumford; M B Fraser; N W Wood; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

7.  Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.

Authors:  I S Mackenzie; S V Morant; G A Bloomfield; T M MacDonald; J O'Riordan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-09-19       Impact factor: 10.154

8.  Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases.

Authors:  Eun-Jae Lee; Young-Min Lim; Seungmi Kim; Lynkyung Choi; Hyunjin Kim; Keonwoo Kim; Hye Weon Kim; Ji Sung Lee; Kwang-Kuk Kim
Journal:  Ann Clin Transl Neurol       Date:  2020-06-04       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.